These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2899099)

  • 1. Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? II. Protagonist's viewpoint.
    Swedberg K
    J Am Coll Cardiol; 1988 Aug; 12(2):550-4. PubMed ID: 2899099
    [No Abstract]   [Full Text] [Related]  

  • 2. Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? III. Antagonist's viewpoint.
    Cohn JN
    J Am Coll Cardiol; 1988 Aug; 12(2):554-8. PubMed ID: 2899100
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of neurohormonal activation in the pathophysiology and prognosis of patients with congestive heart failure.
    Kubo SH
    Coron Artery Dis; 1993 Jan; 4(1):4-15. PubMed ID: 7903590
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.
    Dávila DF; Núñez TJ; Odreman R; de Dávila CA
    Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure.
    Reed BN; Street SE; Jensen BC
    Heart Fail Clin; 2014 Oct; 10(4):543-57. PubMed ID: 25217430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurohumoral axis in congestive heart failure.
    Francis GS; Goldsmith SR; Levine TB; Olivari MT; Cohn JN
    Ann Intern Med; 1984 Sep; 101(3):370-7. PubMed ID: 6147109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroendocrine and sympathetic nervous system in congestive heart failure.
    Ferrari R; Ceconi C; Curello S; Visioli O
    Eur Heart J; 1998 Jun; 19 Suppl F():F45-51. PubMed ID: 9651735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure.
    Francis GS
    Am Heart J; 1989 Sep; 118(3):642-8. PubMed ID: 2570521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal systems during progression of heart failure: a review.
    Svanegaard J; Johansen JB; Thayssen P; Haghfelt T
    Cardiology; 1993; 83(1-2):21-9. PubMed ID: 7903208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of heart failure: the role of neurohumoral activation.
    Middlekauff HR; Mark AL
    Intern Med; 1998 Feb; 37(2):112-22. PubMed ID: 9550589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sympathetic nervous system and pathophysiology of congestive heart failure.
    Farmer J
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):6-11. PubMed ID: 19667705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic nervous system in heart failure.
    Cohn JN
    Circulation; 2002 Nov; 106(19):2417-8. PubMed ID: 12417535
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of beta-blockers on neurohormonal activation in patients with congestive heart failure.
    Baran D; Horn EM; Hryniewicz K; Katz SD
    Drugs; 2000 Nov; 60(5):997-1016. PubMed ID: 11129131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure.
    Packer M
    Eur Heart J; 1995 Jul; 16 Suppl F():4-6. PubMed ID: 8521884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? I. Introduction.
    Massie BM
    J Am Coll Cardiol; 1988 Aug; 12(2):547-50. PubMed ID: 2899098
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic heart failure (IV). The neurohormonal factors in chronic heart failure. Their clinical importance and therapeutic implications].
    Rayo I; Marín Huerta E
    Rev Esp Cardiol; 1991 Dec; 44(10):656-71. PubMed ID: 1686945
    [No Abstract]   [Full Text] [Related]  

  • 17. Catecholamines and their blockade in congestive heart failure.
    White CM
    Am J Health Syst Pharm; 1998 Apr; 55(7):676-82. PubMed ID: 9558423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure.
    Dzau VJ
    Am J Cardiol; 1988 Sep; 62(8):76E-81E. PubMed ID: 2901216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congestive heart failure: pathophysiologic consequences of neurohormonal activation and the potential for recovery: part II.
    Dube P; Weber KT
    Am J Med Sci; 2011 Dec; 342(6):503-6. PubMed ID: 22108172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The background of the MERIT-HF trial.
    Dietz R; Osterziel KJ; Willenbrock R; Hänlein D; von Harsdorf R
    Basic Res Cardiol; 2000; 95 Suppl 1():I84-9. PubMed ID: 11192360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.